Lebwohl M, Sugarman J, Pariser D, Bagel J, Lin T, Israel R. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. J of Skin [Internet]. 2020 Jan. 28 [cited 2024 Jul. 3];4(1):S12. Available from: https://jofskin.org/33014/index.php/skin/article/view/826